Wells Fargo’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14K | Hold |
3,000
| – | – | ﹤0.01% | 5834 |
|
|
2025
Q1 | $2.86K | Buy |
+3,000
| New | +$2.86K | ﹤0.01% | 5642 |
|
|
2024
Q2 | – | Sell |
-175
| Closed | -$662 | – | 6900 |
|
|
2024
Q1 | $662 | Buy |
175
+36
| +26% | +$136 | ﹤0.01% | 5843 |
|
|
2023
Q4 | $716 | Sell |
139
-4,993
| -97% | -$25.7K | ﹤0.01% | 5867 |
|
|
2023
Q3 | $25K | Buy |
5,132
+17
| +0.3% | +$83 | ﹤0.01% | 5144 |
|
|
2023
Q2 | $30K | Buy |
5,115
+5,005
| +4,550% | +$29.3K | ﹤0.01% | 5327 |
|
|
2023
Q1 | $461 | Buy |
110
+1
| +0.9% | +$4 | ﹤0.01% | 6250 |
|
|
2022
Q4 | $463 | Buy |
109
+39
| +56% | +$166 | ﹤0.01% | 6080 |
|
|
2022
Q3 | $0 | Sell |
70
-1
| -1% | – | ﹤0.01% | 6913 |
|
|
2022
Q2 | $0 | Sell |
71
-31
| -30% | – | ﹤0.01% | 7054 |
|
|
2022
Q1 | $0 | Buy |
102
+5
| +5% | – | ﹤0.01% | 7138 |
|
|
2021
Q4 | $0 | Buy |
97
+65
| +203% | – | ﹤0.01% | 7124 |
|
|
2021
Q3 | $0 | Sell |
32
-2
| -6% | – | ﹤0.01% | 7044 |
|
|
2021
Q2 | $0 | Hold |
34
| – | – | ﹤0.01% | 6940 |
|
|
2021
Q1 | $0 | Buy |
+34
| New | – | ﹤0.01% | 6874 |
|